HYQVIA
161503
Approved mab completed
Quick answer
HYQVIA for Primary Immunodeficiency Diseases (PID) is a Approved program (mab) at Takeda with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Primary Immunodeficiency Diseases (PID)
- Phase
- Approved
- Modality
- mab
- Status
- completed